Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.04B | 10.85B | 10.52B | 10.16B | 9.87B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.04B | 10.85B | 10.52B | 10.16B | 9.87B |
| Cost of Revenue | 7.36B | 7.22B | 7.03B | 6.80B | 6.60B |
| Gross Profit | 3.68B | 3.63B | 3.50B | 3.36B | 3.28B |
| SG&A Expenses | 1.92B | 1.89B | 1.83B | 1.76B | 1.73B |
| Depreciation & Amortization | 154.00M | 154.00M | 147.00M | 137.00M | 127.00M |
| Other Operating Expenses | 2.00M | 4.00M | 2.00M | 1.00M | 1.00M |
| Total Operating Expenses | 9.43B | 9.27B | 9.01B | 8.69B | 8.46B |
| Operating Income | 1.60B | 1.58B | 1.52B | 1.47B | 1.42B |
| Income Before Tax | 1.36B | 1.33B | 1.29B | 1.21B | 1.19B |
| Income Tax Expenses | 314.00M | 301.00M | 289.00M | 266.00M | 273.00M |
| Earnings from Continuing Operations | 1.05K | 1.03K | 1.00K | 948.00 | 921.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.00M | -57.00M | -54.00M | -51.00M | -50.00M |
| Net Income | 992.00M | 969.00M | 950.00M | 897.00M | 871.00M |
| EBIT | 1.60B | 1.58B | 1.52B | 1.47B | 1.42B |
| EBITDA | 2.17B | 2.14B | 2.06B | 1.98B | 1.91B |
| EPS Basic | 8.86 | 8.63 | 8.47 | 8.02 | 7.78 |
| Normalized Basic EPS | 7.41 | 7.19 | 6.92 | 6.70 | 6.59 |
| EPS Diluted | 8.77 | 8.55 | 8.38 | 7.94 | 7.72 |
| Normalized Diluted EPS | 7.33 | 7.10 | 6.83 | 6.62 | 6.52 |
| Average Basic Shares Outstanding | 446.00M | 446.00M | 446.00M | 445.00M | 445.00M |
| Average Diluted Shares Outstanding | 451.00M | 452.00M | 452.00M | 451.00M | 450.00M |
| Dividend Per Share | 3.20 | 3.15 | 3.10 | 3.05 | 3.00 |
| Payout Ratio | 35.58% | 35.81% | 36.00% | 37.46% | 38.00% |